Moore Capital Management’s BioAmber Inc. BIOA.WS Stock Holding History

Moore Capital Management’s Portfolio BIOA.WS Stock Details BIOA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-255,000	Closed	-$11K	–	273
2017 Q1	$11K	Hold	255,000	–	–	﹤0.01%	193
2016 Q4	$179K	Hold	255,000	–	–	0.01%	173
2016 Q3	$122K	Hold	255,000	–	–	﹤0.01%	250
2016 Q2	$92K	Hold	255,000	–	–	﹤0.01%	261
2016 Q1	$462K	Hold	255,000	–	–	0.02%	211
2015 Q4	$360K	Hold	255,000	–	–	0.01%	264
2015 Q3	$454K	Hold	255,000	–	–	0.02%	256
2015 Q2	$490K	Hold	255,000	–	–	0.01%	392
2015 Q1	$405K	Hold	255,000	–	–	0.01%	393
2014 Q4	$403K	Hold	255,000	–	–	0.01%	289
2014 Q3	$625K	Hold	255,000	–	–	0.01%	370
2014 Q2	$652K	Buy	+255,000	New	+$580K	0.02%	373
2014 Q1	–	Sell	-255,000	Closed	-$186K	–	597
2013 Q4	$186K	Hold	255,000	–	–	﹤0.01%	360
2013 Q3	$204K	Sell	255,000 -50,000	-16%	-$37.4K	﹤0.01%	344
2013 Q2	$168K	Buy	+305,000	New	+$194K	﹤0.01%	283

Moore Capital Management's BIOA.WS Position: Q2 2017 in Review

Moore Capital Management sold out of BioAmber Inc. (BIOA.WS) in Q2 2017, closing a stake of 255,000 shares — an estimated $11K sold.

Moore Capital Management first reported a position in BIOA.WS in Q2 2013 and held it in 15 quarters. The position peaked at $652K in Q2 2014. 0 funds tracked by Wall St. Rank hold BIOA.WS as of Q2 2017.

Moore Capital Management reported no remaining BioAmber Inc. position as of Q2 2017 after selling out during the quarter.
Moore Capital Management sold 255,000 BioAmber Inc. shares in Q2 2017, an estimated $11K.
Moore Capital Management first reported a position in BioAmber Inc. in Q2 2013 and held it in 15 quarters.
Moore Capital Management's BioAmber Inc. position peaked at $652K in Q2 2014.
0 funds tracked by Wall St. Rank held BioAmber Inc. as of Q2 2017.

Based on Moore Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.